Search Clinical Trials
Home >  Clinical Trials & Research >  Search Clinical Trials
Print

Clinical Trials & Research

Search Clinical Trials

Clinical Trials

New Search
Title   A Study of an Anti-KIR Antibody Lirilumab in Combination With an Anti-PD1 Antibody Nivolumab and Nivolumab Plus an Anti-CTLA-4 Ipilimumab Antibody in Patients With Advanced Solid Tumors
Disease/Condition   Hematologic Diseases,Oncology (Medical/Hematologic)
Description  

Click here for more information

Eligibility Criteria   Click here for eligibility requirements
Principal Investigator   Balazs Halmos, MD
Contact Name   Jeff Lafleur
Contact Email   jeff.lafleur@einstein.yu.edu
Protocol Number   17-06-163-01
Inclusion/Notes   This information was obtained from ClinicalTrials.gov.
Adult Clinical Trial   Yes
Pediatric Clinical Trial   No